What is “Voydeya” (renmixx/rolapitant-related confusion) and where does NDA 218037 fit?
“Voydeya” appears to be associated with Immunovant product branding (often discussed alongside Voquenza/Voydeya naming confusion in searches), but the details you provided—NDA 218037 and a 218037 submission date / approval timeline—point to a specific FDA drug-review record. With only the fragment “Voydeya nda 218037 submission date approval timeline,” I can’t reliably identify which exact drug name and application corresponds to NDA 218037, so I can’t give an accurate timeline without the FDA record details.
How to get the exact submission and approval dates for NDA 218037
To find the precise “submission date” and approval timeline, the fastest route is the FDA’s application-page data for NDA 218037 (this includes key milestones like original submission and FDA action/approval). If you paste either:
- the FDA link you’re using for NDA 218037, or
- the drug/generic name tied to NDA 218037,
then I can translate the FDA milestones into a clear approval timeline.
What the “approval timeline” usually includes for an NDA
When people search this, they typically want:
- Original submission date (when the NDA was first filed)
- Filing/acceptance date
- FDA review start milestones (often linked to review clock status)
- FDA action date (PDUFA date or action date)
- Approval date (label/approval letter date)
- Any major amendment/supplement checkpoints (if the drug wasn’t in one clean submission)
If you’re tracking “Voydeya” specifically, which milestone date matters most?
For patient and commercial timelines, the most commonly cited dates are:
- FDA approval date (when the drug becomes officially approved)
- Launch timing (often later, driven by manufacturing/coverage)
- PDUFA/action date (market expectations date)
But the correct mapping depends entirely on which FDA application ID is truly “Voydeya.”
Send one missing detail so I can answer with exact dates
Please provide one of the following:
1) the drug name that corresponds to NDA 218037, or
2) a URL/screenshot of the FDA page for NDA 218037.
Then I’ll return the exact submission date and a concise approval timeline (submission → filing → review clock milestones → action date → approval date), with sources.
Sources
No sources were used because the NDA 218037 record details weren’t provided, and I can’t safely infer the exact drug/timeline from “Voydeya nda 218037” alone.